These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21349035)

  • 1. Recommendations for reporting adverse drug reactions and adverse events of traditional Chinese medicine.
    Wu T; Shang H; Bian Z; Zhang J; Li T; Li Y; Zhang B
    J Evid Based Med; 2010 Feb; 3(1):11-7. PubMed ID: 21349035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chinese medicine adverse reactions' literature statistical analysis in recent five years].
    Xiang F; Zhang X
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2755-8. PubMed ID: 22242443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving reporting of adverse events and adverse drug reactions following injections of Chinese materia medica.
    Bian ZX; Tian HY; Gao L; Shang HC; Wu TX; Li YP; Zhang BL; Song L
    J Evid Based Med; 2010 Feb; 3(1):5-10. PubMed ID: 21349034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions and adverse events of 33 varieties of traditional Chinese medicine injections on National Essential medicines List (2004 edition) of China: an overview on published literatures.
    Wang L; Yuan Q; Marshall G; Cui X; Cheng L; Li Y; Shang H; Zhang B; Li Y
    J Evid Based Med; 2010 May; 3(2):95-104. PubMed ID: 21349051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influencing factor and mechanism analysis of adverse drug reaction in traditional Chinese medicine injection].
    Wei X; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2748-51. PubMed ID: 23285926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections].
    Wang HN; Chen W; Fu Z; Du WM; He J
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):612-4. PubMed ID: 18536393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Probing into objectivity of adverse drug reaction of traditional Chinese medicine].
    Sun YQ; Ma YG; Xing XY; Xiao XH
    Zhongguo Zhong Yao Za Zhi; 2006 Aug; 31(16):1381-3. PubMed ID: 17061563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case study of Chinese medicine after listing of pharmacovigilance].
    Xiang Y; Xie Y; Yi D
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2836-9. PubMed ID: 22292379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Discussion on establishment of quality control system for intensive hospital monitoring on traditional Chinese medicine injections].
    Jiang JJ; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2689-91. PubMed ID: 23285909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.
    Clark JA; Humphries JE; Crean S; Reynolds MW
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):107-14. PubMed ID: 20014051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring].
    Wang D; Du XX
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2686-8. PubMed ID: 23285908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the knowledge and attitude to adverse drug reactions reporting among healthcare professionals in Wuhan city].
    Li Q; Zhang SM; Chen HT; Fang SP; Yu X; Liu D; Shi LY; Zeng FD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Oct; 25(10):894-7. PubMed ID: 15631751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of adverse reactions to injections of Chinese materia medica.
    Bian Z; Shang H; Cheng C; Wu T; Li Y; Zhang B
    J Evid Based Med; 2010 May; 3(2):88-94. PubMed ID: 21349050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status and development of monitoring on adverse reaction of traditional Chinese medicine in China].
    Zhang L; Yang XH; Cao LY; Ji S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jul; 25(7):581-4. PubMed ID: 16089130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interactions and adverse drug reactions: how to obtain information].
    Fattinger KE
    Praxis (Bern 1994); 1999 Apr; 88(16):713-8. PubMed ID: 10355337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
    Su C; Ji H; Su Y
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions reporting by physicians in Ibadan, Nigeria.
    Okezie EO; Olufunmilayo F
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):517-22. PubMed ID: 18404621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thinking on risk assessment and risk management of post-marketing Chinese medicine].
    Yu X; Xie Y; Wang Y
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(2):262-4. PubMed ID: 22737865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
    Mey C; Hentschel H; Hippius M; Balogh A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the reporting of adverse drug reactions in the hospital setting.
    Pushkin R; Frassetto L; Tsourounis C; Segal ES; Kim S
    Postgrad Med; 2010 Nov; 122(6):154-64. PubMed ID: 21084792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.